Stimulant and non-stimulant agents for ADHD This medication guide details the different types of treatments for attention deficit hyperactivity disorder, for both adults and children.…
Antidepressants added to PCN structured medication review list From 2025/2026, primary care networks are required to include people using antidepressants for structured medication reviews as part of medicines optimisation processes for “high-risk cohorts”.…
More than half of pharmacy staff struggle with mental health over medicines shortages, reveals survey Respondents to the Royal Pharmaceutical Society Workforce Wellbeing Survey also cited inadequate staffing, lack of work–life balance and increased financial pressures as factors that negatively impact their mental health.…
Antidepressant use associated with increased hospitalisation in treatment of bipolar disorder, research suggests Of the specific monotherapies analysed, only lithium was associated with lower depression-related hospitalisation risk.…
The novel schizophrenia drug showing renewed potential for better outcomes A novel acetylcholine receptor drug has become the first new medicine to treat schizophrenia in decades. But even after gaining approval in the United States, experts are still conflicted on its benefits over current antipsychotic medicines.…
Recognition and management of delirium An overview of delirium, its symptoms and subtypes, including how to assess and diagnose, with an overview of non-pharmacological and pharmacological management.…
Enhancing medicines safety for people with learning disabilities and autism through STOMPHealthcare professionals will be familiar with ‘The Oliver McGowan mandatory training on learning disability and autism’. This training serves as a powerful reminder of the devastating consequences related to inappropriate prescribing and emphasises the need for reform in how we manage medicines…
Around 360,000 patients at risk of being ‘trapped’ on antipsychotics, researchers warn The British Journal of General Practice's cross-sectional study highlights that between 360,000 and 390,000 patients in the UK could be being prescribed long-term antipsychotics "without regular psychiatric review”.…
Government-funded trial will test psilocybin as treatment for opioid use disorder The project is one of four funded by the National Institute for Health and Care Research aimed at cutting harm from illegal drugs.…
Prescribing nature to boost mental health This episode of The PJ Pod looks at the evidence for green social prescribing and how pharmacists can help their patients to connect with nature.…
